GRIFFANTE, Gloria
 Distribuzione geografica
Continente #
EU - Europa 176
NA - Nord America 83
AS - Asia 68
Totale 327
Nazione #
US - Stati Uniti d'America 79
IT - Italia 72
IE - Irlanda 37
SG - Singapore 37
DE - Germania 23
HK - Hong Kong 19
SE - Svezia 15
BE - Belgio 9
FR - Francia 6
TR - Turchia 6
LT - Lituania 5
CA - Canada 4
CN - Cina 3
FI - Finlandia 3
GB - Regno Unito 3
CZ - Repubblica Ceca 2
IR - Iran 2
JP - Giappone 1
UA - Ucraina 1
Totale 327
Città #
Dublin 35
Singapore 32
Hong Kong 15
Piemonte 12
Turin 11
Boardman 9
Chandler 9
Antwerp 8
Milan 8
Bremen 5
Frankfurt am Main 5
Munich 5
Jacksonville 4
Lawrence 4
Princeton 4
Strasbourg 4
Toronto 4
Helsinki 3
Padova 3
Vercelli 3
Ashburn 2
Bari 2
Brno 2
Fairfield 2
Genzano di Roma 2
Grafing 2
Paris 2
Wilmington 2
Andover 1
Brussels 1
Citta 1
Concorezzo 1
Fort Worth 1
Freiburg im Breisgau 1
Guangzhou 1
Harbin 1
Leawood 1
London 1
Monmouth Junction 1
Morioka 1
Mülheim 1
Oleggio 1
Sabz 1
San Mateo 1
Santa Clara 1
Seattle 1
Trivero 1
Zanjan 1
Totale 219
Nome #
Toll-like receptor 4-mediated inflammation triggered by extracellular IFI16 is enhanced by lipopolysaccharide binding 61
SARS-CoV-2 re-infection in a cancer patient with a defective neutralizing humoral response 46
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 41
Persistence of neutralizing antibodies to SARS-CoV-2 in first wave infected individuals at ten months post-infection: The UnIRSA cohort study 34
Human cytomegalovirus infection triggers a paracrine senescence loop in renal epithelial cells 29
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients 27
Exploiting Lipid Metabolism by HSV-1: a Challenge to Rethink New Therapies for Alzheimer’s Disease 21
Cancer-Associated Fibroblasts Exert Proangiogenic Activity in Merkel Cell Carcinoma 19
Characterization of citrullination during infection with DNA and RNA viruses: a new strategy for host-targeting antivirals drugs 7
Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors 6
Exploiting lipid metabolism by HSV-1 – a challenge to rethink new therapies for Alzheimer's disease 6
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 6
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 5
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 5
IFI16 IMPACTS METABOLIC REPROGRAMMING DURING HUMAN CYTOMEGALOVIRUS INFECTION 5
NOVEL ANTIVIRAL ACTIVITY OF PADS INHIBITORS AGAINST HUMAN BETA-CORONAVIRUSES SARS-COV-2 AND HCOV-OC43 5
Citrullination upon viral infection: a new strategy for host-targeting antivirals drugs 5
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 5
Herpesvirus-mediated protein citrullination as a new target for antiviral therapy 5
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 4
The Impact of Fatty Acid Synthase on HSV-1 Infectivity Unveils the Key Interconnection with Alzheimer’s Disease 4
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 3
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 3
Totale 352
Categoria #
all - tutte 2.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.926


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 3 2 3 2 1 4 3 0
2021/202241 3 1 1 2 1 4 3 6 1 4 5 10
2022/202390 8 1 6 3 6 9 7 4 36 2 4 4
2023/202472 7 3 4 2 9 2 5 2 0 0 23 15
2024/2025131 3 29 40 16 38 5 0 0 0 0 0 0
Totale 352